Q. Song, X. An, F. Che, and T. Shen
Vol 000
+
4
.09 (d, J= 32.2 Hz, 2H), 2.96 (d, J= 13.7 Hz, 1H), 2.83 (d, J=6.3Hz,
64.42, 52.85, 48.29, 30.60, 27.17, 21.23; MS m/z 422 (M ). Anal.
+
2H), 1.79 (s, 2H); MS m/z 869 (M ). Anal. Calcd. for C H N O : C,
Calcd. For C H N O : C, 79.59; H, 6.20; N, 6.63. Found: C, 79.55;
6
0
56
2
4
28 26 2 2
82.92; H, 6.49; N, 3.22. Found: C, 82.90; H, 6.45; N, 3.24%.
H, 6.29; N, 6.67%.
2
,2′-((1E,1′E)-(((Butane-1,4-diylbis(oxy))bis(2,1-phenylene))
(1′R,2′S)-2′-Benzoyl-5-chloro-1′-phenyl-1′,2′,5′,6′,7′,7a′-
hexahydrospiro[indoline-3,3′-pyrrolizin]-2-one (5j). White
bis(methanylylidene))bis(azanylylidene))bis(1,1,2-triphenylethanol)
5f). White powder; yield 75%; mp 217–221°C; IR (KBr, cm ):
278, 3059, 2968, 2869, 1591, 1547, 1491, 1447, 1177, 1029, 971,
À1
À1
(
3
7
(
2
(
(
(
powder; yield 82%; IR (KBr, cm ): 3414, 3027, 2955, 2936,
1
2873, 1730, 1676, 1365, 1305, 1164, 982, 861; H NMR
1
71, 740, 698, 538; H NMR (500 MHz, DMSO) δ 8.27 (s, 1H), 7.86
d, J= 7.5 Hz, 1H), 7.46–7.42 (m, 2H), 7.33 (dd, J= 10.5, 3.1 Hz,
H), 7.21 (d, J= 2.3 Hz, 1H), 7.10 (dd, J= 14.6, 7.2 Hz, 2H), 7.02
t, J= 7.3 Hz, 1H), 6.76 (s, 1H), 5.58 (d, J= 5.2 Hz, 1H), 4.26–4.18
m, 1H), 4.13 (s, 1H), 4.07–3.99 (m, 1H), 1.99 (s, 1H), 0.91–0.76
m, 1H); MS m/z 841 (M ). Anal. Calcd. for C58
H, 6.23; N, 3.33. Found: C, 82.81; H, 6.25; N, 3.35%.
General procedure for synthesis of spiro pyrrolizines
g–5j. A mixture of isatin (1.0 mmol), L-proline (1.2mmol),
and chalcone (1.1 mmol) in methanol was refluxed for 6 h and
then cooled to room temperature. The solvent was removed under
reduced pressure, and the crude product obtained was purified by
column chromatography using petroleum ether/ethyl acetate (4:1)
as eluent.
3
(500 MHz, CDCl ) δ 8.39 (s, 1H), 7.52 (d, J = 7.3 Hz, 2H), 7.44
(dd, J = 8.2, 1.1 Hz, 2H), 7.38–7.30 (m, 3H), 7.25–7.17 (m, 4H),
7.12 (dd, J = 8.3, 2.1Hz, 1H), 4.95 (d, J = 11.4 Hz, 1H), 4.26 (dt,
J = 9.8, 6.3 Hz, 1H), 3.89 (dd, J = 11.0, 10.3Hz, 1H), 3.49 (s, 1H),
2.73–2.62 (m, 2H), 2.10–2.01 (m, 1H), 2.01–1.89 (m, 2H),
+
13
H
52
N
2
O
4
: C, 82.83;
3
1.80–1.72 (m, 1H); C NMR (126 MHz, CDCl ) δ 196.65,
180.32, 139.37, 139.11, 136.99, 133.04, 129.50, 128.73, 128.24,
128.08, 127.92, 127.84, 127.77, 127.09, 126.89, 110.90, 77.27,
77.01, 76.76, 73.47, 72.00, 64.45, 52.87, 48.18, 30.54, 27.31; MS
5
+
m/z 442 (M ). Anal. Calcd. For C H ClN O : C, 73.21; H,
2
7
23
2 2
5.23; N, 6.32. Found: C, 73.25; H, 5.29; N, 6.27%.
General procedure for synthesis of DHPMs (4a–4j). After
stirring a solution of HCl (10 mol%), 1a (0.5 mmol), and urea
(0.75 mmol), in 2 mL of THF at 67°C for 1 h, catalyst 5d (10 mol
%) and ethyl acetoacetate (1.5 mmol) were added sequentially.
Then, the crude product was purified by recrystallization with
ethanol to afford 4a–4j.
(
3′S,4′R)-3′-Benzoyl-1′-isopropyl-4′-phenylspiro[indoline-
3
,2′-pyrrolidin]-2-one (5g). White crystal; yield 89%; IR (KBr,
À1
cm ): 3188, 3060, 2963, 2870, 1734, 1677, 1616, 1470, 1448,
1
1
385, 1329; H NMR (500 MHz, CDCl
J= 7.3 Hz, 2H), 7.40–7.35 (m, 2H), 7.32 (dd, J= 12.4, 4.6 Hz, 3H),
.20 (dd, J=7.2, 5.9Hz, 2H), 7.16 (t, J=7.8Hz, 2H), 7.02
td, J= 7.6, 1.2Hz, 1H), 6.98 (dd, J= 11.0, 4.0 Hz, 1H), 6.47
d, J= 7.5 Hz, 1H), 4.64 (d, J= 10.6 Hz, 1H), 4.04 (t, J= 10.7 Hz,
H), 3.94 (dd, J= 10.7, 4.4 Hz, 1H), 2.16 (s, 1H), 1.83
qd, J= 11.3, 6.8 Hz, 1H), 0.99 (d, J = 6.8 Hz, 3H), 0.92
d, J=6.9Hz, 3H); C NMR (126 MHz, CDCl ) δ 197.36, 181.96,
40.63, 139.87, 137.23, 132.71, 129.93, 129.11, 128.66, 128.49,
28.09, 127.62, 126.81, 125.73, 123.07, 109.38, 77.29, 77.03,
3
) δ 7.79 (s, 1H), 7.55 (d,
Ethyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-
1
carboxylate (4a). White solid; yield 92%; mp 199–203°C; H
7
(
(
1
(
(
1
1
7
NMR (500 MHz, DMSO): δ (ppm) 1.09 (t, J= 7.2Hz, 3H), 2.25
(s, 3H), 3.98 (dd, J = 7.2 Hz, 14.4 Hz, 2H), 5.15 (d, J = 2.8 Hz, 1H),
7.23–7.34 (m, 5H), 7.74 (s, 1H), 9.19 (s, 1H).
Ethyl-6-methyl-4-(2-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-
1
5-carboxylate (4b). White solid; yield 96%; mp 218–221°C; H NMR
13
(500 MHz, DMSO): δ (ppm) 1.21 (t, J= 7.4 Hz, 3H), 2.26 (s, 3H), 4.20
(dd, J= 7.0 Hz, 14.2 Hz, 2H), 5.13 (d, J= 2.8 Hz, 1H), 7.47 (s, 1H), 7.52
(s, 1H), 7.70 (s, 1H), 7.96 (s, 1H), 8.31 (d, J= 8.8 Hz, 2H).
3
6.78, 69.62, 68.64, 64.14, 51.18, 30.26, 20.52, 17.42; MS m/z 410
Ethyl-6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-
+
1
(
M ). Anal. Calcd. for C27
24 2 2
H N O : C, 79.00; H, 6.38; N, 6.82.
5-carboxylate (4c). White solid; yield 95%; mp 227–231°C; H NMR
Found: C, 78.97; H, 6.34; N, 6.78%.
1′R,2′S)-2′-Benzoyl-1′-phenyl-1′,2′,5′,6′,7′,7a′-hexahydrospiro
indoline-3,3′-pyrrolizin]-2-one (5h). White crystal; yield 84%;
IR (KBr, cm ):3363, 3184, 3030, 2959, 2114, 1896, 1618, 1352,
(500 MHz, DMSO): δ (ppm) 1.29 (t, J= 7.2 Hz, 3H), 2.23 (s, 3H), 4.18
(dd, J= 7.2 Hz, 14.2 Hz, 2H), 5.12 (d, J= 2.8 Hz, 1H), 7.59 (s, 1H), 7.62
(s, 1H), 8.07 (s, 1H), 8.12 (s, 1H), 8.48 (d, J= 8.8 Hz, 2H).
(
[
À1
Ethyl-6-methyl-4-(4-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-
1
1
1
(
(
067; H NMR (500 MHz, CDCl
d, J=7.3Hz, 2H), 7.42–7.38 (m, 2H), 7.37–7.30 (m, 3H), 7.27
d, J=7.6Hz, 4H), 7.23 (d, J= 7.3 Hz, 1H), 7.19 (dd, J= 13.4,
3
) δ 7.84 (s, 1H), 7.53
5-carboxylate (4d). White solid; yield 98%; mp 205–208°C; H NMR
(500 MHz, DMSO): δ (ppm) 1.11 (t, J= 7.2 Hz, 3H), 2.29 (s, 3H), 4.00
(dd, J= 7.2 Hz, 14.4 Hz, 2H), 5.29 (d, J=2.8Hz, 1H), 7.52 (d,
J= 8.8 Hz, 2H), 7.90 (s, 1H), 8.23 (d, J=8.8Hz, 2H), 9.37 (s, 1H).
Ethyl-4-(4-fluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-
5
1
.7 Hz, 2H), 7.13 (td, J=7.7, 0.9Hz, 1H), 7.03 (dd, J=7.7, 7.1Hz,
H), 6.56 (d, J= 7.7 Hz, 1H), 4.96 (d, J= 11.4 Hz, 1H), 4.28 (dt,
1
J=9.8, 6.3Hz, 1H), 3.96–3.89 (m, 1H), 2.76–2.60 (m, 2H), 2.05
td, J= 12.2, 7.0 Hz, 1H), 1.99–1.87 (m, 2H), 1.77 (dt, J= 13.2,
5-carboxylate (4e). White solid; yield 97%; mp 182–186°C; H NMR
(
7
(500 MHz, DMSO): δ (ppm) 1.09 (t, J= 6.8 Hz, 3H), 2.25 (s, 3H), 3.98
(dd, J= 6.8 Hz, 13.6 Hz, 2H), 5.15 (d, J=2.8Hz, 1H), 7.13–7.17 (m, 2H),
7.25–7.29 (m, 2H), 7.76 (s, 1H), 9.24 (s, 1H).
+
.6 Hz, 3H); MS m/z 408 (M ). Anal. Calcd. for C H N O : C,
27 24 2 2
7
9.39; H, 5.92; N, 6.86. Found: C, 79.36; H, 5.93; N, 6.87%.
1′R,2′S)-2′-Benzoyl-5-methyl-1′-phenyl-1′,2′,5′,6′,7′,7a′-
(
Ethyl-4-(4-chlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-
1
hexahydrospiro[indoline-3,3′-pyrrolizin]-2-one (5i).
powder; yield 80%; IR (KBr, cm ): 3665, 3359, 3071, 3025, 2969,
White
5-carboxylate (4f). White solid; yield 98%; mp 211–215°C; H NMR
À1
(500 MHz, DMSO): δ (ppm) 1.09 (t, J= 7.2 Hz, 3H), 2.25 (s, 3H), 2.26
(s, 3H), 3.98 (dd, J= 6.6 Hz, 13.8 Hz, 2H), 5.15 (d, J= 2.4 Hz, 1H), 7.25
(d, J=8.1Hz, 2H), 7.39 (d, J= 8.1 Hz, 2H), 7.78 (s, 1H), 9.26 (s, 1H).
Ethyl-4-(4-bromophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-
1
2
874, 1715, 1682, 1616, 1475, 1446, 1283, 998; H NMR (500 MHz,
CDCl ) δ 7.92 (s, 1H), 7.54 (d, J= 7.3 Hz, 2H), 7.43–7.38 (m, 2H),
.34 (dt, J= 13.1, 6.5 Hz, 3H), 7.20 (dt, J= 22.3, 7.6 Hz, 3H), 7.05
s, 1H), 6.92 (d, J= 7.8 Hz, 1H), 6.46 (d, J= 7.9 Hz, 1H), 4.94
d, J= 11.4 Hz, 1H), 4.28 (dt, J=9.8, 6.3Hz, 1H), 3.97–3.89 (m, 1H),
.74 (dt, J= 14.5, 7.2 Hz, 1H), 2.69–2.62 (m, 1H), 2.36 (s, 3H), 2.06
td, J= 12.2, 7.0 Hz, 1H), 1.99–1.88 (m, 2H), 1.78 (dt, J= 13.2,
3
7
(
(
2
(
7
1
1
1
5-carboxylate (4g). White solid; yield 97%; mp 206–209°C; H NMR
(500 MHz, DMSO): δ (ppm) 1.09 (t, J= 6.6 Hz, 3H), 2.26 (s, 3H), 3.99
(dd, J= 6.3 Hz, 13.2 Hz, 2H), 5.14 (d, J= 2.8 Hz, 1H), 7.20 (d, J=8.1Hz,
2H), 7.53 (d, J= 7.8 Hz, 2H), 7.77 (s, 1H), 9.25 (s, 1H).
13
.6 Hz, 1H); C NMR (126 MHz, CDCl
38.23, 137.19, 132.78, 131.70, 129.81, 128.67, 128.15, 128.08,
27.89, 126.96, 124.97, 109.72, 77.29, 77.03, 76.78, 73.59, 72.04,
3
) δ 197.11, 180.65, 139.83,
Ethyl-6-methyl-2-oxo-4-(p-tolyl)-1,2,3,4-tetrahydropyrimidine-
1
5-carboxylate (4h). White solid; yield 78%; mp 233–236°C; H
NMR (500 MHz, DMSO): δ (ppm) 1.10 (t, J = 7.0 Hz, 3H), 2.25 (s,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet